phosphorylcholine has been researched along with Diabetes Mellitus in 4 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yousf, S | 1 |
| Sardesai, DM | 1 |
| Mathew, AB | 1 |
| Khandelwal, R | 1 |
| Acharya, JD | 1 |
| Sharma, S | 1 |
| Chugh, J | 1 |
| Cseh, A | 1 |
| Szebeni, B | 1 |
| Szalay, B | 1 |
| Vásárhelyi, B | 1 |
| Wakita, H | 1 |
| Matsushita, K | 1 |
| Nishimura, K | 1 |
| Tokura, Y | 1 |
| Furukawa, F | 1 |
| Takigawa, M | 1 |
| Byrne, JJ | 1 |
| Bradlow, HL | 1 |
4 other studies available for phosphorylcholine and Diabetes Mellitus
| Article | Year |
|---|---|
Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.
Topics: Animals; Apoptosis; Biomarkers; Diabetes Mellitus; Disease Models, Animal; Fatty Acids, Nonesterifie | 2019 |
[Akt enzyme: new therapeutic target in cancer and diabetes?].
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Diabetes Mellitus; Enzyme Activ | 2009 |
Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
Topics: Animals; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Diabetes Mellitus; DNA; Female; Hum | 1998 |
DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.
Topics: Animals; Blood Glucose; Dehydroepiandrosterone; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug C | 2001 |